New research has taken a significant step in terms of research and care for acromegaly, a rare disease caused by an excess of growth hormone secretion, which occurs in over 99% of cases due to a ...
People with the rare growth hormone disorder acromegaly have a significantly higher risk of developing various types of cancer, often at ages younger than typically seen in the general population, ...
SAN FRANCISCO—People with the rare growth hormone disorder acromegaly have a significantly higher risk of developing various types of cancer, often at ages younger than typically seen in the general ...
ACRO/TRUTH Provides Authentic Patient Perspectives, Peer-Reviewed Data on Treatment-Related Symptoms, Side Effects and Quality-of-Life Impact of Current Acromegaly Standard-of-Care SAN DIEGO, Aug. 08, ...
ZURICH, May 5 (Reuters) - Swiss drugmaker Novartis said on Monday a final-stage trial of its Signifor LAR therapy allowed for greater disease control in patients with the endocrine disorder acromegaly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results